Omnia SanaPlant Comparison
Wormwood vs Meadowsweet
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Wormwood and Meadowsweet: they share 9 indicated uses (arthritis / joint pain, cancer (anticancer research), indigestion, …); 5 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Wormwood | Meadowsweet | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Indigestion | 1/10 | 1/10 | Comparable evidence |
| Infection (general) | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Menstrual cramps | 1/10 | 1/10 | Comparable evidence |
| Muscle spasm | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Intensely bitter sesquiterpene lactones responsible for the classic digestive-bitter action.
Volatile oil containing thujone (alpha- and beta-isomers), the neurotoxic ketone that limits safe internal use, along with other monoterpenes.
Antioxidant constituents contributing to the plant's antioxidant activity.
Historically the source of aspirin's chemical inspiration; provide the plant's analgesic and anti-inflammatory activity, buffered by co-occurring mucilage and tannins.
Antioxidant constituents contributing to the plant's anti-inflammatory and gastroprotective effects.
Contribute to astringency and the characteristic sweet almond-like fragrance.
Pharmacological Actions
Artemisia absinthium (wormwood) total flavonoids and its constituent alpha/beta-thujone induce ROS- and caspase-mediated apoptosis in cervical and choriocarcinoma cancer cells (preclinical).
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
Artemisia absinthium (wormwood) total flavonoids (cynaroside, astragalin) inhibit HeLa cervical cancer cells via ROS-mediated apoptosis, and its terpenoid alpha,beta-thujone induces caspase-dependent apoptosis in choriocarcinoma cells and sensitizes them to paclitaxel (preclinical).
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antispasmodic action
inferred from antidiabetic action
inferred from antispasmodic action
inferred from anti-inflammatory action
inferred from gastroprotective action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from gastroprotective action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
inferred from diuretic action
inferred from diuretic action
inferred from diuretic action
Safety, Cautions & Contraindications
CAUTION: Contains thujone, which is neurotoxic in significant amounts. Internal use should be limited in duration and dose — short-term use only (under 4 weeks). Contraindicated in pregnancy (powerful uterine stimulant). Avoid in epilepsy, renal disease, and in children. The small amounts present in properly prepared bitter tinctures and vermouth are generally considered safe. The thujone content of absinthe was historically exaggerated.
Duke (2002) rates wormwood as + (use with caution) and provides clinical evidence (score 2) for use as an aperitif and bitter digestive tonic, consistent with Commission E approval for dyspeptic complaints and loss of appetite. The plant contains absinthin and artabsin (bitter sesquiterpene lactones) responsible for digestive stimulation, and also thujone — a neurotoxic ketone that is the active agent responsible for 'absinthism' (historical neurological syndrome linked to absinthe consumption). Duke strongly cautions that thujone content limits safe long-term use, and wormwood should not be taken internally for more than 4 weeks at a time. Strictly contraindicated in pregnancy (abortifacient, neurotoxic) and epilepsy (Duke, 2002).
Generally safe in normal culinary and medicinal doses. Avoid in salicylate sensitivity or aspirin allergy. Not recommended for children with viral illnesses (Reye's syndrome risk, as with other salicylate-containing plants). Avoid during pregnancy and breastfeeding.
Duke (2002) rates meadowsweet as ++ and notes analgesic, antiulcer, antirheumatic, astringent, and anti-aggregant activities at the experimental level (score 1). The plant is historically significant as a precursor to aspirin — salicylate compounds in meadowsweet were originally used to derive acetylsalicylic acid. Unlike aspirin, meadowsweet's salicylates are combined with protective mucilaginous compounds that may reduce gastric irritation. Duke notes that individuals with aspirin (salicylate) sensitivity should avoid meadowsweet; the plant also has anticoagulant properties that may interact with blood-thinning medications (Duke, 2002).
External Ids
Botanical Description
Aromatic, silvery-grey perennial herb with finely divided, silky-hairy leaves and numerous small, pale yellow, drooping, globe-shaped flower heads borne in loose branched panicles. The whole plant has a characteristic intensely bitter taste and a pungent, sage-like aroma.[4]
Tall, moisture-loving perennial herb with pinnately compound leaves, dark green above and whitish-downy beneath, the leaflets sharply toothed. Dense, fluffy, creamy-white flower clusters with a strong, sweet, almond-like fragrance are borne atop reddish, grooved stems.[1]
Habitat
Grows on dry, sunny, stony or waste ground, roadsides and field margins; native to Europe, North Africa and temperate Asia, and naturalised in North America.[4]
Grows in damp meadows, marshes, riverbanks, ditches and wet woodland margins; native to Europe and temperate Asia, favouring moist, nutrient-rich ground.[1]
Harvesting
The flowering aerial parts (leaf, stem and flower) are cut as flowering begins, in mid- to late summer, and dried in a warm, shaded, airy place.[4]
The flowering tops, leaf and stem are cut in summer as the flowers open, when the characteristic salicylate content is highest, and dried in a warm, shaded, airy place.[1]
Traditional Uses
Meadowsweet is historically significant as the plant from which salicylic acid derivatives (the chemical basis of aspirin) were first isolated, and has long been used in European folk medicine as an anti-inflammatory, analgesic and gastroprotective remedy for feverish colds, rheumatic and joint pain, and digestive complaints such as acid reflux and indigestion - notably, its natural mucilage is thought to buffer the gastric irritation associated with isolated salicylates.[1, 4]
Preparations
Dried flowering herb infused briefly in hot water as a very bitter digestive tea, taken before meals to stimulate appetite.
Dried flower, leaf and stem infused in hot water as a traditional anti-inflammatory and digestive tea.
Tincture (1:5) of the dried aerial parts; single dose 2-4 ml, daily dose 6-12 ml per the EU herbal monograph. Educational reference only, not a prescription.
Concentrated extract studied in vitro and in vivo for anti-inflammatory and gastroprotective activity.
Dosage
Because of its thujone content, traditional herbal references limit internal use to small bitter doses (around 0.5-1 g dried herb per cup) for no more than about 4 weeks at a time. Educational reference only, not a prescription.
The EU herbal monograph gives a single dose of 1.5-6 g of the comminuted herb as an infusion, for a daily dose of 2-18 g, in adults and elderly; a powdered herbal substance at 250-500 mg per dose (250-1500 mg daily) and a 1:5 tincture at 2-4 mL per dose (6-12 mL daily) are also listed. Contraindicated in hypersensitivity to salicylates. For rheumatic-type complaints, not to be used for more than 4 weeks. Not recommended under 18 years. Educational reference only, not a prescription.
References
Lookalikes Review
References & Sources
- Batiha, G.E.S., Olatunde, A., El-Mleeh, A., Hetta, H.F., Al-Rejaie, S. et al (2020) 'Bioactive Compounds, Pharmacological Actions, and Pharmacokinetics of Wormwood (Artemisia absinthium)', Antibiotics (Basel), 9(6), pp. 353. doi:10.3390/antibiotics9060353 Traditional / reference
https://doi.org/10.3390/antibiotics9060353 - Wubuli, A., Abdulla, R., Zhao, J., Wu, T. and Aisa, H.A (2024) 'Exploring anti-inflammatory and antioxidant-related quality markers of Artemisia absinthium L. based on spectrum-effect relationship', Phytochemical Analysis, 35(5), pp. 1152-1173. doi:10.1002/pca.3350 Preclinical
https://doi.org/10.1002/pca.3350 - Rashidi, R., Akaberi, M., Gholoobi, A., Ghazavi, H. and Forouzanfar, F (2023) 'Artemisia absinthium Extract Attenuates the Quinolinic Acid-Induced Cell Injury in OLN-93 Cells', Current Drug Discovery Technologies, 20(4), pp. e300323215213. doi:10.2174/1570163820666230330105331 Preclinical
https://doi.org/10.2174/1570163820666230330105331 - Szopa, A., Pajor, J., Klin, P., Rzepiela, A., Elansary, H.O., Al-Mana, F.A., Mattar, M.A. and Ekiert, H (2020) 'Artemisia absinthium L. - Importance in the History of Medicine, the Latest Advances in Phytochemistry and Therapeutical, Cosmetological and Culinary Uses', Plants, 9(9), pp. 1063. doi:10.3390/plants9091063 Meta-analysis / review
https://doi.org/10.3390/plants9091063 - Hbika, A., Daoudi, N.E., Bouyanzer, A., Bouhrim, M., Mohti, H., Loukili, E.H., Mechchate, H., Al-Salahi, R., Nasr, F.A., Bnouham, M. and Zaid, A (2022) 'Artemisia absinthium L. Aqueous and Ethyl Acetate Extracts: Antioxidant Effect and Potential Activity In Vitro and In Vivo against Pancreatic alpha-Amylase and Intestinal alpha-Glucosidase', Pharmaceutics, 14(3), pp. 481. doi:10.3390/pharmaceutics14030481 Preclinical
https://doi.org/10.3390/pharmaceutics14030481 - Bagheri, F., Amri, J., Salehi, M., Karami, H., Alimoradian, A. and Latifi, S.A (2020) 'Effect of Artemisia absinthium ethanolic extract on oxidative stress markers and the TLR4, S100A4, Bax and Bcl-2 genes expression in the kidney of STZ-induced diabetic rats', Hormone Molecular Biology and Clinical Investigation, 41(4), pp. 20200028. doi:10.1515/hmbci-2020-0028 Preclinical
https://doi.org/10.1515/hmbci-2020-0028 - Al-Malki, A.L (2018) 'Shikimic acid from Artemisia absinthium inhibits protein glycation in diabetic rats', International Journal of Biological Macromolecules, 122, pp. 1212-1216. doi:10.1016/j.ijbiomac.2018.09.072 Preclinical
https://doi.org/10.1016/j.ijbiomac.2018.09.072 - Boeing, T., de Souza, J., Vilhena da Silva, R.C., Mariano, L.N.B., Mota da Silva, L., Gerhardt, G.M., Cretton, S., Klein-Junior, L.C. and de Souza, P (2023) 'Gastroprotective effect of Artemisia absinthium L.: A medicinal plant used in the treatment of digestive disorders', Journal of Ethnopharmacology, 312, pp. 116488. doi:10.1016/j.jep.2023.116488 Preclinical
https://doi.org/10.1016/j.jep.2023.116488 - Liu, Z., Li, X., Jin, Y., Nan, T., Zhao, Y., Huang, L. and Yuan, Y (2023) 'New Evidence for Artemisia absinthium as an Alternative to Classical Antibiotics: Chemical Analysis of Phenolic Compounds, Screening for Antimicrobial Activity', International Journal of Molecular Sciences, 24(15), pp. 12044. doi:10.3390/ijms241512044 Preclinical
https://doi.org/10.3390/ijms241512044 - Moaca, E., Pavel, I.Z., Danciu, C., Crainiceanu, Z., Minda, D., Ardelean, F., Antal, D.S., Ghiulai, R., Cioca, A., Derban, M., Simu, S., Chioibas, R., Szuhanek, C. and Dehelean, C (2019) 'Romanian Wormwood (Artemisia absinthium L.): Physicochemical and Nutraceutical Screening', Molecules, 24(17), pp. 3087. doi:10.3390/molecules24173087 Preclinical
https://doi.org/10.3390/molecules24173087 - Turak, A., Shi, S., Jiang, Y. and Tu, P (2014) 'Dimeric guaianolides from Artemisia absinthium', Phytochemistry, 105, pp. 109-114. doi:10.1016/j.phytochem.2014.06.016 Preclinical
https://doi.org/10.1016/j.phytochem.2014.06.016 - Correa-Ferreira, M.L., Noleto, G.R. and Oliveira Petkowicz, C.L (2013) 'Artemisia absinthium and Artemisia vulgaris: a comparative study of infusion polysaccharides', Carbohydrate Polymers, 102, pp. 738-745. doi:10.1016/j.carbpol.2013.10.096 Preclinical
https://doi.org/10.1016/j.carbpol.2013.10.096 - Grieve, M (1931) 'A Modern Herbal'. Traditional / reference
https://scholar.google.com/scholar?q=A%20Modern%20Herbal - Hoffmann, D (2003) 'Medical Herbalism'. Traditional / reference
https://scholar.google.com/scholar?q=Medical%20Herbalism - Lee, J.-Y. and Park, H. and Lim, W. and Song, G (2020) 'alpha,beta-Thujone suppresses human placental choriocarcinoma cells via metabolic disruption', Reproduction, 159(6), pp. 745-756. doi:10.1530/REP-20-0018 Preclinical
https://doi.org/10.1530/REP-20-0018 - He, M. and Yasin, K. and Yu, S. and Li, J. and Xia, L (2023) 'Total Flavonoids in Artemisia absinthium L. and Evaluation of Its Anticancer Activity', International Journal of Molecular Sciences, 24(22), pp. 16348. doi:10.3390/ijms242216348 Preclinical
https://doi.org/10.3390/ijms242216348 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Samardžić, S., Arsenijević, J., Božić, D., Milenković, M. et al (2017) 'Antioxidant, anti-inflammatory and gastroprotective activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench', Journal of Ethnopharmacology, 213, pp. 132-137. doi:10.1016/j.jep.2017.11.013 Preclinical
https://doi.org/10.1016/j.jep.2017.11.013 - Andonova, T., Muhovski, Y., Apostolova, E., Naimov, S. et al (2024) 'DNA-Protective, Antioxidant and Anti-Carcinogenic Potential of Meadowsweet (Filipendula ulmaria) Dry Tincture', Antioxidants (Basel), 13(10), pp. 1200. doi:10.3390/antiox13101200 Preclinical
https://doi.org/10.3390/antiox13101200 - Van der Auwera, A., Peeters, L., Foubert, K., Piazza, S. et al (2023) 'In Vitro Biotransformation and Anti-Inflammatory Activity of Constituents and Metabolites of Filipendula ulmaria', Pharmaceutics, 15(4), pp. 1291. doi:10.3390/pharmaceutics15041291 Preclinical
https://doi.org/10.3390/pharmaceutics15041291 - Katanic, J., Boroja, T., Mihailovic, V., Nikles, S., Pan, S., Rosic, G., Selakovic, D., Joksimovic, J., Mitrovic, S. and Bauer, R (2016) 'In vitro and in vivo assessment of meadowsweet (Filipendula ulmaria) as anti-inflammatory agent', Journal of Ethnopharmacology, 193, pp. 627-636. doi:10.1016/j.jep.2016.10.015 Preclinical
https://doi.org/10.1016/j.jep.2016.10.015 - Samardzic, S., Tomic, M., Pecikoza, U., Stepanovic-Petrovic, R. and Maksimovic, Z (2016) 'Antihyperalgesic activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench in a rat model of inflammation', Journal of Ethnopharmacology, 193, pp. 652-656. doi:10.1016/j.jep.2016.10.024 Preclinical
https://doi.org/10.1016/j.jep.2016.10.024 - Katanic, J., Matic, S., Pferschy-Wenzig, E., Kretschmer, N., Boroja, T., Mihailovic, V., Stankovic, V., Stankovic, N., Mladenovic, M., Stanic, S., Mihailovic, M. and Bauer, R (2016) 'Filipendula ulmaria extracts attenuate cisplatin-induced liver and kidney oxidative stress in rats: In vivo investigation and LC-MS analysis', Food and Chemical Toxicology, 99, pp. 86-102. doi:10.1016/j.fct.2016.11.018 Preclinical
https://doi.org/10.1016/j.fct.2016.11.018 - Arsenijevic, N., Selakovic, D., Katanic Stankovic, J.S., Mihailovic, V., Mitrovic, S., Milenkovic, J., Milanovic, P., Vasovic, M., Nikezic, A., Milosevic-Djordjevic, O., Zivanovic, M., Filipovic, N., Jakovljevic, V., Jovicic, N. and Rosic, G (2021) 'Variable neuroprotective role of Filipendula ulmaria extract in rat hippocampus', Journal of Integrative Neuroscience, 20(4), pp. 871-883. doi:10.31083/j.jin2004089 Preclinical
https://doi.org/10.31083/j.jin2004089 - Matic, S., Katanic, J., Stanic, S., Mladenovic, M., Stankovic, N., Mihailovic, V. and Boroja, T (2015) 'In vitro and in vivo assessment of the genotoxicity and antigenotoxicity of the Filipendula hexapetala and Filipendula ulmaria methanol extracts', Journal of Ethnopharmacology, 174, pp. 287-292. doi:10.1016/j.jep.2015.08.025 Preclinical
https://doi.org/10.1016/j.jep.2015.08.025 - Pannakal, S.T., Eilstein, J., Hubert, J., Kotland, A., Prasad, A., Gueguiniat-Prevot, A., Juchaux, F., Beaumard, F., Seru, G., John, S. and Roy, D (2023) 'Rapid Chemical Profiling of Filipendula ulmaria Using CPC Fractionation, 2-D Mapping of 13C NMR Data, and High-Resolution LC-MS', Molecules, 28(17), pp. 6349. doi:10.3390/molecules28176349 Preclinical
https://doi.org/10.3390/molecules28176349 - Valle, M.G., Nano, G.M. and Tira, S (1988) 'The Essential Oil of Filipendula ulmaria', Planta Medica, 54(2), pp. 181-182. doi:10.1055/s-2006-962390 Preclinical
https://doi.org/10.1055/s-2006-962390 - Popowski, D., Zentek, J., Piwowarski, J.P. and Granica, S (2021) 'Gut Microbiota of Pigs Metabolizes Extracts of Filipendula ulmaria and Orthosiphon aristatus - Herbal Remedies Used in Urinary Tract Disorders', Planta Medica, 88(3-04), pp. 254-261. doi:10.1055/a-1647-2866 Preclinical
https://doi.org/10.1055/a-1647-2866 - Bespalov, V.G., Alexandrov, V.A., Semenov, A.L., Kovan'ko, E.G., Ivanov, S.D., Vysochina, G.I., Kostikova, V.A. and Baranenko, D.A (2016) 'The inhibitory effect of meadowsweet (Filipendula ulmaria) on radiation-induced carcinogenesis in rats', International Journal of Radiation Biology, 93(4), pp. 394-401. doi:10.1080/09553002.2016.1257834 Preclinical
https://doi.org/10.1080/09553002.2016.1257834 - European Medicines Agency (HMPC) (2011) 'Community herbal monograph on Filipendula ulmaria (L.) Maxim., herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-filipendula-ulmaria-l-maxim-herba-first-version_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-filipendula-ulmaria-l-maxim-herba-first-version_en.pdf - Bridge, J (2008) 'The Herbal Remedy Handbook'. Traditional / reference
https://scholar.google.com/scholar?q=The%20Herbal%20Remedy%20Handbook - Drummond, E.M., Harbourne, N., Marete, E., Jacquier, J.C., O'Riordan, D. and Gibney, E.R (2013) 'Inhibition of pro-inflammatory biomarkers in THP1 macrophages by polyphenols derived from chamomile, meadowsweet and willow bark', 27(4), pp. 588--594. Traditional / reference
https://scholar.google.com/scholar?q=Inhibition%20of%20pro-inflammatory%20biomarkers%20in%20THP1%20macrophages%20by%20polyphenols%20derived%20from%20chamomile%2C%20meadowsweet%20and%20willow%20bark - Grieve, M (1931) 'A Modern Herbal'. Traditional / reference
https://scholar.google.com/scholar?q=A%20Modern%20Herbal - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.